Prosecution Insights
Last updated: April 19, 2026
Application No. 18/076,752

METHOD FOR PRODUCING REDUCED GLYCOL FATTY ALCOHOL ETHOXYLATES, REDUCED GLYCOL SULFATE ETHOXYLATED SURFACTANTS, AND PRODUCTS

Non-Final OA §103
Filed
Dec 07, 2022
Examiner
OGDEN JR, NECHOLUS
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
The Procter & Gamble Company
OA Round
3 (Non-Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
2y 11m
To Grant
93%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allow Rate
714 granted / 1026 resolved
+4.6% vs TC avg
Strong +24% interview lift
Without
With
+23.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
42 currently pending
Career history
1068
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
49.1%
+9.1% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
16.4%
-23.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1026 resolved cases

Office Action

§103
Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 1-2-2026 has been entered. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-9 is/are rejected under 35 U.S.C. 103 as being unpatentable over EP (2421813). EP ‘813 discloses In a first aspect, the present invention generally relates to a two step process for the preparation of non-ionic surfactants, specifically, alcohol ethoxylates of the general structure (I):         R-(OCH.sub.2CH.sub.2)n-OH     (I) In a second aspect, the invention relates to alcohol ethoxylates of formula (I) made from the aforementioned process, wherein said alcohol ethoxylates have a narrow distribution range, low free alcohol content, and low ether/diacetal content. In a third aspect, the invention relates to provide a process for preparing a low foaming, non-gelling anionic surfactant having the general formula (II):         R-(OCH.sub.2CH.sub.2)n-OSO.sub.3M     (II) In a fourth aspect, the invention relates to alkyl ether sulfates of formula (II), which possess low foam, non-gelling properties while retaining their surfactancy and penetrating power. In a fifth aspect, the present invention relates to the use of alkyl ether sulphates of formula (III) as adjutants in agriculturally active formulations (0005-0011).         R'-x(OCH.sub.2CH.sub.2)-O-(CH.sub.2CH.sub.2O).sub.y-R'     (III) Thus, the quantity of ethylene oxide used in this stage is regulated to control the concentrate of the "surfactancy booster" in the final non-ionic product as needed to obtain its optimum performance in the designed application. For example, in certain embodiments, up to 2 moles of EO per mole of fatty alcohol (R-OH) could be used in this stage. In a preferred embodiment, the non-ionic surfactant resulting from the inventive process will include less than 8%, and even more preferably less than 5%, of the starting, unreacted alcohol (0015-0016; 0021-0023). In another embodiment, the invention relates to an alkyl ether sulfate of the formula (II):         R-(OCH.sub.2CH.sub.2).sub.n-OSO.sub.3M     (II) where R is a straight, branched or cyclic chain, saturated or unsaturated alkyl group containing 6 - 11 carbon atoms and n is an integer of from 3- 6. In another embodiment, R is a branched alkyl group. The ether sulfates of the present invention preferably comprise at least about 75% solids and up to and including about 25% water. To possess low foam, non-gelling properties while retaining their surfactancy and penetrating power, embodiments of ether sulfates in accordance with the invention preferably include, based on its solids, at least about 80%, and more preferably at least about 85% of alkyl ether sulfate homologs having from 1 to 2n ethylene oxide units in their hydrophilic group. Further, embodiments of the invention also include anionic surfactants comprising ether sulfates that include less than about 15%, and more preferably less than about 10% of alkyl ether sulfate homologs that have more than 2n ethylene oxide units in their hydrophilic group. The ether sulfates of the present invention also preferably include less than about 8%, and preferably less than about 5% of the non-ethoxylate alkyl sulfate (0033-0035). EP ‘813 disclose the single component in the surfactant product and further suggest the broad nature of producing ethoxylated alcohols and sulfated alcohol ethoxylates having free alcohol contents as described. The office bears a lessen burden when discloses the compounds and binary components of said invention but is silent with respect to the process of producing said product. Since the products are named and described, the process of producing the same is considered prima facie obvious. “The Patent Office bears a lesser burden of proof in making out a case of prima facie obviousness for product-by-process claims because of their peculiar nature” than when a product is claimed in the conventional fashion. In re Fessmann, 489 F.2d 742, 744, 180 USPQ 324, 326 (CCPA 1974). Once the examiner provides a rationale tending to show that the claimed product appears to be the same or similar to that of the prior art, although produced by a different process, the burden shifts to applicant to come forward with evidence establishing an unobvious difference between the claimed product and the prior art product. Claim(s) 1-9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Fox et al (2002/151449). Fox et al disclose a cleaning composition comprising an ethoxylated fatty alcohol, surfactant, such as (iso)tridecyl alcohol ethoxylate, and specifically Iconal TDA-3 (020-021), 6%-21% EFA and 10-90% water (see examples II-III, V, IX, XI, XIN, XV, XVIII and XIX). Fox et al discloses at least one cleaning composition comprising an ethoxylated fatty alcohol surfactant, such as (iso)tridecyl alcohol ethoxylate and between 10 to 90 wt.% of water; see the examples Il, Ill, V, IX, XI, XIN, XV, XVIII and XIX. With respect to the “free alcohol” it is interpreted as the compound is named and the amount of free alcohol is an optional limitation. One skilled in the art in the absence of a showing to the contrary, would envision the alkoxylate surfactant of Fox et al as the same or similar compound in the absence of a showing to the contrary. 17. Fox et al disclose the single component in the surfactant product and further suggest the broad nature of producing ethoxylated alcohols and sulfated alcohol ethoxylates having free alcohol contents as described. The office bears a lessen burden when discloses the compounds and binary components of said invention but is silent with respect to the process of producing said product. Since the products are named and described, the process of producing the same is considered prima facie obvious. 18. “The Patent Office bears a lesser burden of proof in making out a case of prima facie obviousness for product-by-process claims because of their peculiar nature” than when a product is claimed in the conventional fashion. In re Fessmann, 489 F.2d 742, 744, 180 USPQ 324, 326 (CCPA 1974). Once the examiner provides a rationale tending to show that the claimed product appears to be the same or similar to that of the prior art, although produced by a different process, the burden shifts to applicant to come forward with evidence establishing an unobvious difference between the claimed product and the prior art product. When the species is clearly named, the species claim is anticipated no matter how many other species are additionally named. Ex parte A, 17 USPQ2d 1716 (Bd. Pat. App. & Inter. 1990) See also In re Sivaramakrishnan, 673 F.2d 1383, 213USPQ 441 (CCPA 1982). Response to Arguments Applicant's arguments filed 1-2-2026 have been fully considered but they are not persuasive. Applicant argues: that the presence of free glycol and/or diethylene glycol monosulfate sodium within the respective alcohol ethoxylates (fatty or sulfated) at a level pf 100 ppm or less. Figures 1-2 and 5 show the 1,4-dioxane formed (ppm) over time (weeks) in raw materials aged at ranging temperatures (30°-50°C). Sodium laureth-1 sulfate (SLE1S), sodium laureth-3 sulfate (SLE3S), and sodium trideceth-2 sulfate (ST2S) at varying active percentages were among the raw materials observed. Such data supports the finding that even raw fatty alcohol ethoxylates (i.e. Iconal TDA-3 surfactant taught in Fox) that initially show almost no amounts of 1,4-dioxane can still show formation of the undesirable byproduct over time. For example, Figure 9 experimentally validates that diethylene glycol monosulfate can spontaneously convert to 1,4-dioxane. The examiner contends and respectfully disagrees since none of the examples are commensurate in scope with the claimed invention nor are any of the examples compared to the closest prior art of record, Fox et al. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NECHOLUS OGDEN JR whose telephone number is (571)272-1322. The examiner can normally be reached 8-4:30 EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 571-272-1498. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NECHOLUS OGDEN JR/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Dec 07, 2022
Application Filed
Jun 10, 2025
Non-Final Rejection — §103
Sep 12, 2025
Response Filed
Sep 30, 2025
Final Rejection — §103
Jan 02, 2026
Request for Continued Examination
Jan 06, 2026
Response after Non-Final Action
Feb 19, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595435
DETERGENT COMPOSITIONS
2y 5m to grant Granted Apr 07, 2026
Patent 12576019
PERSONAL CLEANSING COMPOSITION WITH AN ORGANIC ACID HAVING A PKA GREATER THAN 2.7
2y 5m to grant Granted Mar 17, 2026
Patent 12577502
USE OF PROPOXYLATED SURFACTANT OR POLYMER IN FOAMING APPLICATIONS TO CONTROL VISCOELASTICITY IN HIGHLY ACTIVE LIQUID FORMULATIONS
2y 5m to grant Granted Mar 17, 2026
Patent 12576013
DISSOLVABLE SOLID FIBROUS SHAMPOO ARTICLES CONTAINING SALTS
2y 5m to grant Granted Mar 17, 2026
Patent 12564549
CLEANSER COMPOSITION
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
93%
With Interview (+23.6%)
2y 11m
Median Time to Grant
High
PTA Risk
Based on 1026 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month